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ABSTRACT Mucormycosis is an emerging fungal infection with extremely high mor-
tality rates in patients with defects in their innate immune response, speciﬁcally in
functions mediated through phagocytes. However, we currently have a limited un-
derstanding of the molecular and cellular interactions between these innate immune
effectors and mucormycete spores during the early immune response. Here, the
early events of innate immune recruitment in response to infection by Mucor cir-
cinelloides spores are modeled by a combined in silico modeling approach and real-
time in vivo microscopy. Phagocytes are rapidly recruited to the site of infection in a
zebraﬁsh larval model of mucormycosis. This robust early recruitment protects from
disease onset in vivo. In silico analysis identiﬁed that protection is dependent on the
number of phagocytes at the infection site, but not the speed of recruitment. The
mathematical model highlights the role of proinﬂammatory signals for phagocyte re-
cruitment and the importance of inhibition of spore germination for protection from
active fungal disease. These in silico data are supported by an in vivo lack of fungal
spore killing and lack of reactive oxygen burst, which together result in latent fungal
infection. During this latent stage of infection, spores are controlled in innate granu-
lomas in vivo. Disease can be reactivated by immunosuppression. Together, these
data represent the ﬁrst in vivo real-time analysis of innate granuloma formation dur-
ing the early stages of a fungal infection. The results highlight a potential latent
stage during mucormycosis that should urgently be considered for clinical manage-
ment of patients.
IMPORTANCE Mucormycosis is a dramatic fungal infection frequently leading to
the death of patients. We know little about the immune response to the fungus
causing this infection, although evidence points toward defects in early immune
events after infection. Here, we dissect this early immune response to infectious fun-
gal spores. We show that specialized white blood cells (phagocytes) rapidly respond
to these spores and accumulate around the fungus. However, we demonstrate that
the mechanisms that enable phagocytes to kill the fungus fail, allowing for survival
of spores. Instead a cluster of phagocytes resembling an early granuloma is formed
around spores to control the latent infection. This study is the ﬁrst detailed analysis
of early granuloma formation during a fungal infection highlighting a latent stage
that needs to be considered for clinical management of patients.
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Mucormycosis is the second most common fungal mold infection and is associatedwith extremely high mortality (up to90% in disseminated infection) (1). Disease
is caused by a spectrum of species belonging to the Mucorales (e.g., Rhizopus oryzae,
Mucor circinelloides, and Lichtheimia corymbifera). Symptoms are due to spore germi-
nation and ﬁlamentous fungal growth within the host leading to angioinvasion, vessel
thrombosis, and tissue necrosis (2–4). Although little epidemiological data is available
for mucormycosis, estimates suggest approximately 10,000 infections are due to Rhi-
zopus oryzae annually (5, 6). Individuals with hematopoietic disorders or transplants are
particularly at risk of disease, with 8 and 16% of patients, respectively, presenting with
mucormycosis (5). Mucormycosis is considered an emerging disease, with reported 7.3
and 9.3% increases in incidence and mortality between 2001 and 2010, respectively (7).
Treatment of mucormycosis is very costly, with an average expense of $100,000 per
case, and remains unsuccessful in most cases (8). Current antifungal therapy for
mucormycosis is ineffective, and treatment involves extensive surgical removal of
infected tissue, often leading to limb amputation and long-term disability. Therefore,
there is clearly a clinical need for a more effective treatment strategy.
Mucorales are opportunistic pathogens. Thus, understanding how the immune
system naturally prevents pathological disease and identifying the crucial components
may inform future targets for mucormycosis therapy. Susceptible patients often present
with innate immune defects (for example, neutropenia and impaired macrophage or
neutrophil functions) due to uncontrolled diabetes or corticosteroid therapy (1, 5, 9,
10). This highlights the essential role of phagocytes for an effective immune response
to mucormycosis. To counteract the immune response, there is strong evidence for an
immune-inhibitory effect of infectious fungal spores (11, 12).
Traditional animal models to study the pathogenesis of mucormycosis have been
limited and do not allow for the integrative study of cellular interactions (13). Host
expression studies of R. oryzae infections in the fruit ﬂy (Drosophila melanogaster)
infection model showed downregulation of genes in several pathways, including
pathogen recognition, immune defense, and stress responses (14). Murine bronchoal-
veolar macrophages inhibit germination of R. oryzae spores and thus prevent formation
of invasive hyphal forms in the healthy host (11, 12, 15, 16). However, macrophages
and neutrophils are unable to kill fungal spores (11, 12, 17). In addition, macro-
phages from diabetic or corticosteroid-treated mice fail to inhibit spore germina-
tion (15, 18). Despite this, the molecular and cellular interactions during the early
immune response to mucormycete spores are poorly understood. Yet, this infor-
mation may offer an immunomodulatory target for protection from disease onset.
Using our in vivo larval zebraﬁsh (Danio rerio) model of mucormycosis, we previ-
ously demonstrated that macrophages and neutrophils are rapidly recruited to the
site of infection with M. circinelloides (17).
In this study, we model the early events of innate immune recruitment in response
to M. circinelloides spores by a combined in silico modeling and real-time microscopy
approach in vivo. Utilizing our recently established zebraﬁsh infection model (17), we
took advantage of the optical transparency of zebraﬁsh larvae, which allow for real-time
microscopy, to model the early temporal-spatial events of innate immune recruitment
in response to fungal spores in vivo. We combined this experimental analysis with
mathematical modeling to identify the essential parameters for protection from path-
ological disease. We showed that robust early phagocyte recruitment is crucial for
protection from disease. Proinﬂammatory cytokine signals (e.g., early transcription
response of the tnf- and and il-8 genes, coding for tumor necrosis factor alpha [TNF-]
and interleukin-8 [IL-8], respectively) are important for induction of effective phagocyte
recruitment. Yet, our data suggest that protection is dependent on the capacity, rather
than the rate, of phagocyte recruitment to the site of infection. At the site of infection,
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phagocytes form tight clusters around spores resembling early granulomas. While
spores are successfully contained in these early granulomas, which we term innate
granulomas, we observe a lack of reactive oxygen burst and failure to kill fungal spores.
Moreover, disease can be reactivated by dexamethasone (Dex)-induced immunosup-
pression. Together, this is the ﬁrst real-time analysis of innate granuloma formation
during the early stages of a fungal infection. Our data indicate the potential for a latent
infectious stage during mucormycosis that needs to be considered for clinical man-
agement of patients.
RESULTS
Phagocytes are rapidly recruited to the site of Mucor circinelloides infection in
vivo. Zebraﬁsh larvae do not have an adaptive immune system and rely on their innate
immune cells to respond to infectious stimuli. We took advantage of this characteristic
to deﬁne the phagocyte response to infection with M. circinelloides asexual spores. We
used transgenic zebraﬁsh larvae with ﬂuorescently tagged macrophages [Tg(mpeg1:
G/U:NfsB-mCherry)] and neutrophils [Tg(mpx:GFP)] to assess whole-larval phagocyte
number. Phagocyte recruitment was observed by ﬂuorescence microscopy in unin-
jected larvae or after microinjection of control medium (polyvinylpyrrolidone [PVP]) or
100 M. circinelloides spores in the hindbrain ventricle of 36-h-old zebraﬁsh larvae
(Fig. 1A). Phagocyte numbers were counted before microinjection and every 24 h after
injection. Both macrophage and neutrophil numbers increased with larval age, even in
untreated larvae (Fig. 1B and C). However, the total numbers of macrophages (P 
0.001, two-way analysis of variance [ANOVA]) and neutrophils (P  0.001, two-way
ANOVA) in the whole larvae increased 11.2- and 5.6-fold, respectively, following spore
injection compared to 5.0- and 3.2-fold increases, respectively, in control-injected larvae
(Fig. 1B and C). This suggested a global innate immune response to M. circinelloides
infection in this model system.
Next, we wanted to understand how this global increase in phagocyte numbers
correlates to phagocyte recruitment to the site of infection. We previously conducted
real-time imaging to qualitatively illustrate that phagocytes are recruited in response to
M. circinelloides spores in our in vivo zebraﬁsh larval hindbrain ventricle model (17).
Here, we analyzed these movies quantitatively by high-resolution tracking of phago-
cyte movement from the whole ﬁsh toward infectious fungal spores at the site of
infection using the software Volocity. Data were analyzed for the ﬁrst 14 h postinfection
(hpi). Mean ﬂuorescence intensity (MFI) for mCherry-tagged macrophages and green
ﬂuorescent protein (GFP)-tagged neutrophils was measured at the site of infection in
transgenic zebraﬁsh larvae. Infected larvae exhibit rapid onset of macrophage recruit-
ment to the site of infection with live spores. The number of macrophages steadily
increased until maximum recruitment was achieved 12 hpi (Fig. 1D). Macrophage
recruitment in response to infection with dead spores was 2.1-fold lower (P  0.0001,
analysis of covariance) (Fig. 1D). Onset of neutrophil recruitment was delayed until
4 hpi, after which neutrophil recruitment proceeded until 9 hpi, when maximum
recruitment was reached (Fig. 1E). There were 3.0-fold fewer neutrophils recruited to
the site of infection in response to dead spores compared to injection with live spores
(P  0.0001, analysis of covariance) (Fig. 1E).
Collectively, these data show that zebraﬁsh respond rapidly to infection with live
M. circinelloides spores both by increasing their phagocyte number and by recruiting
phagocytes to the site of infection.
Robust early phagocyte recruitment protects from Mucor circinelloides in vivo.
Immunosuppression predisposes individuals to mucormycosis. However, the mecha-
nism for this enhanced susceptibility is not fully understood. We employed dexameth-
asone (40 g/ml), a well-established corticosteroid that mimics immune inhibition in
the context of mucormycosis (17, 19, 20), to analyze the impact on phagocyte recruit-
ment after infection with mucormycete spores. Our zebraﬁsh model lacks a fully
functional adaptive immune system. In this context, dexamethasone’s immune-
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inhibitory effects would most likely affect the innate immune response by inhibiting
proinﬂammatory mechanisms.
Dexamethasone-treated larvae infected in the hindbrain ventricle exhibited signif-
icantly increased mortality relative to untreated larvae (67.2% versus 36.1%; P 0.0001,
Mantel-Cox log-rank test) (Fig. 2A). This difference is most visible 96 hpi, mostly likely
due the invasive fungal growth having reached the critical threshold leading to host
death. At the same time, dexamethasone treatment signiﬁcantly reduced the numbers
of macrophages (1.7-fold; P  0.0001, Mann-Whitney U test) and neutrophils (1.5-fold;
FIG 1 Phagocytes are rapidly recruited to the site of infection with live Mucor circinelloides in vivo. (A)
Schematic of a prim-25 zebraﬁsh embryo indicating the site of infection (the hindbrain ventricle) in red.
(B and C) Macrophage and neutrophil total body numbers were monitored in Tg(mpeg1:G/U:NfsB-
mCherry) and Tg(mpx:GFP) zebraﬁsh larvae, respectively, in uninjected larvae, or after injection of control
medium (PVP) or 100 spores into the hindbrain of 36-hpf larvae. Phagocyte numbers were counted
before microinjection and every 24 h after injection. Both macrophage and neutrophil numbers increase
with larval age, while spore exposure signiﬁcantly increases the total number of macrophages (B) and
neutrophils (C). Individual data points and the mean average and standard error of the mean are
presented. Statistical analysis was performed on data using two-way ANOVA with Tukey’s multiple-
comparison test (***, P  0.001; ns, not signiﬁcant). (D and E) Macrophage and neutrophil recruitment
in response to Mucor circinelloides was monitored by real-time microscopy over 12 h, starting 2 h
postinfection in transgenic zebraﬁsh Tg(mpeg1:G/U:NfsB-mCherry/mpx:GFP) larvae (17), and recruitment
was assessed by mean ﬂuorescence intensity measurements using Volocity image analysis software.
Macrophages (D) and neutrophils (E) were rapidly recruited to the site of infection of live spores.
Recruitment was signiﬁcantly reduced in response to dead spores (P  0.0001, analysis of covariance).
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P  0.0001, Mann-Whitney U test) recruited to the site of infection 24 hpi (Fig. 2B and
C). We followed the fate of these larvae and recorded the time of larval death. There
was a strong correlation between the numbers of macrophages (P  0.0001, Pearson
correlation) and neutrophils (P  0.0001, Pearson correlation) and the time of mortality
(Fig. 2D and E). While macrophage and neutrophil numbers were signiﬁcantly reduced
at the site of infection after dexamethasone treatment, the corticosteroid did not alter
overall phagocyte numbers (whole body) or inhibit the global increase in phagocyte
numbers in response to the infectious stimulus (see Fig. S1 in the supplemental
material). Whole-larval phagocytes also outnumbered recruited phagocytes, indicating
that recruitment was not limited by phagocyte availability (Fig. 1B and C and 2B and C;
Fig. S1).
Taken together, these data suggest that phagocyte recruitment to the site of
infection is an essential aspect in the prevention of morbidity and mortality. Moreover,
phagocyte numbers recruited to the site of infection 24 hpi may have predictive value
for disease progression and/or outcome.
The importance of phagocyte recruitment for protection from Mucor circinel-
loides can be modeled by an in silico approach. Our experimental data demonstrate
that whole-ﬁsh phagocyte count does not predict outcome. Rather, local phagocyte
numbers at the site of infection affect infection outcome. To investigate this further, we
took a mathematical modeling approach to perturb parameters affecting the system of
interest, either individually or in combination. Such an investigation is relatively
straightforward compared to its experimental equivalent and can yield vital insight into
a system and help to guide future experimental work. We therefore modeled infection
FIG 2 Robust phagocyte recruitment protects from Mucor circinelloides in vivo. General immunosuppression was induced
in zebraﬁsh larvae with the steroid dexamethasone (40 g/ml), and zebraﬁsh were monitored for mortality and phagocyte
recruitment. (A) Dexamethasone treatment signiﬁcantly increased larval mortality after infection with fungal spores (P 
0.001, Mantel-Cox log-rank test) while signiﬁcantly reducing the number of macrophages and neutrophils recruited to the
hindbrain ventricle (site of infection) in Tg(mpeg1:G/U:NfsB-mCherry) (B) and Tg(mpx:GFP) (C) embryos, respectively, 24 hpi
(P 0.0001, Mann-Whitney U test). (D and E) The number of macrophages and neutrophils at the site of infection at 24 hpi
was signiﬁcantly correlated with the time of observed death of infected zebraﬁsh (P  0.0001, Pearson correlation). A
higher phagocyte number in the hindbrain ventricle at 24 hpi resulted in longer larval survival after infection.
Phagocyte Recruitment during Mucor Infection ®
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dynamics using the schematic presented in Fig. 3A and B. We thus present results for
this model based on three categories of zebraﬁsh, each distinguished by their maxi-
mum phagocyte number at the infection site (carrying capacity): an “immunocompro-
mised” zebraﬁsh (maximum macrophage number KM  5, maximum neutrophil num-
ber KN  5), a “susceptible” zebraﬁsh (KM  KN  12), and a “healthy” zebraﬁsh (KM 
KN  20). Our experimental observations showed that if an infected zebraﬁsh survived
until after 96 h postinfection (here denoted as 120-h survival), it was likely to survive the
infection entirely. We thus demark 120 h as a survival point if the number of hyphae has
not yet passed the critical threshold, H*.
We simulated variations in all individual model parameters (Fig. 3A and B) (within
what might be considered a reasonable range) bar KH (which was not deemed to be an
aspect of the system that could be manipulated in practice), while ﬁxing the other
parameters at their default values (with phagocyte carrying capacities as given above)
and recorded the change in predicted survival time (Fig. 3C to E). In agreement with the
experimental ﬁndings that phagocyte number at the site of infection (carrying capacity)
is crucial in inﬂuencing disease outcome, the ability to support survival by varying any
one of the parameters was highly dependent upon the maximum number of phago-
cytes at the infection site. For the “immunocompromised” zebraﬁsh (low KM, KN), only
a decrease in rH (germination rate) or a large increase in KM (macrophage carrying
capacity) changed survival outcome (Fig. 3C). In contrast, survival could be supported
in the “susceptible” zebraﬁsh (intermediate KM, KN) by varying any individual parameter
within the range tested (Fig. 3D). Notably, in these zebraﬁsh simulations, relatively small
increases to parameters associated with the macrophage response (particularly KM)
were sufﬁcient to support survival. While altering the phagocyte recruitment rates (rM,
rN) could also support survival, a large fold increase was required for these parameters:
i.e., the effectiveness of the immune response may be more sensitive to changes in the
maximum number of macrophages present at the infection site than it is to the speed
at which these immune cells can arrive at the infection site. The “healthy” zebraﬁsh
(large KM, KN) could, to an extent, cope with worsened parameter values (e.g., KN  0)
and still survive (Fig. 3E).
Thus, our mathematical model can predict our experimental data that sufﬁcient
phagocyte recruitment to the site of infection is essential for protection from mucor-
mycosis.
In silico modeling indicates that protection from Mucor circinelloides is depen-
dent on maximum phagocyte number at the site of infection. The variation
between our three categories of zebraﬁsh suggests that maximum phagocyte numbers
at the infection site (particularly KM) are not only a critical factor to survival, but are
capable of inﬂuencing the effect of varying the other parameters on survival time: i.e.,
the sensitivity of the immune response to the other parameters varies depending on
the value of KM. To examine this phenomenon further, we varied KM and each other
parameter simultaneously and examined the impact on survival time. We illustrate only
those results for the “susceptible” zebraﬁsh (Fig. 4). Most striking is that, for survival,
some parameters are dispensable with a sufﬁciently high KM. There were minimum
thresholds required for those parameters associated with macrophage function: i.e.,
nonzero rM and M are needed for survival. (The ﬁrst of these is intuitive since
macrophage arrival at the infection site is also required for the secondary neutrophil
response.) By varying rM and KM simultaneously, we see that having a small number of
macrophages arrive quickly at the infection site is likely to be less inﬂuential than
having large numbers arrive more slowly. For sufﬁciently high rH, death was always
predicted before 120 h regardless of KM (in the range tested). Since macrophages are
assumed to be required for neutrophil recruitment, in no case could the infection be
survived if KM  0. Given the dominance of KM in these simulations, equivalent results
for the “immunocompromised” zebraﬁsh are highly similar despite a lower KN value (see
Fig. S2 in the supplemental material).
Taken together, our mathematical model highlights the maximum number of
phagocytes at the site of infection as the critical factor for host survival.
Inglesﬁeld et al. ®
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FIG 3 Mathematical model of the innate immune response to a mucormycosis infection. A schematic
representation is given in panel A, where open-headed arrows illustrate recruitment, solid arrows
(Continued on next page)
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In silico modeling indicates the role of proinﬂammatory signals for phagocyte
recruitment and highlights the role of inhibition of spore germination for pro-
tection from active mucormycosis. Together, our experimental and in silico data
suggest that the presence of phagocytic cells at the site of infection, rather than the
rate at which the pool of available phagocytic cells arrive, is a crucial determinant of
disease outcome. Proinﬂammatory cytokines are well-known stimuli that sequester the
recruitment of immune cells. Patients with reduced proinﬂammatory capacity due to
medical interventions such as corticosteroid treatment have higher risk of mucormy-
cosis (3, 5, 21). We thus assessed the impact of proinﬂammatory cytokine expression on
effective phagocyte recruitment. We modeled a series of time-dependent simulations
representing various proinﬂammatory responses and examined their effects on mucor-
mycosis outcome. We tested the impact of the rates of phagocyte recruitment (rM and
FIG 3 Legend (Continued)
germination, and bars inhibition. Model equations are given in panel B. Phagocytes are assumed to have
a carrying capacity at which they will saturate. Germination is inhibited by the presence of phagocytes.
Variables: S, spores; H, hyphae; M, macrophages; N, neutrophils. Parameters: rM/rN, macrophage/neutro-
phil recruitment rates; KM/KN, macrophage/neutrophil carrying capacities (maximum number at infection
site); rH, spore germination rate; KH, germination saturation constant; M/N, macrophage/neutrophil
germination inhibition coefﬁcients. (C to E) Individual parameter variations to the mathematical model
using three categories of zebraﬁsh: “immunocompromised” (C), “susceptible” (D), and “healthy” (E).
Shown is the impact of variation of individual parameters (indicated by x label) on time taken to reach
H* (indicating death from mucormycosis). The dashed line marks 120 h: where the solid line lies above
the dashed line, zebraﬁsh are deemed to survive for corresponding parameter values. The asterisk
indicates the default parameter value (i.e., prior to variation). The horizontal distance between the
asterisk and the point at which the solid curve crosses the dashed line indicates the required absolute
change to the parameter to support survival.
FIG 4 Double-parameter variations indicate that protection from Mucor circinelloides is dependent on
maximum phagocyte number at the site of infection (varying KM and an additional parameter as
indicated by the y label) as applied to the mathematical model using “susceptible” zebraﬁsh parameters
(KN  12), and impact of their variation on time taken to reach H* (indicating death from mucormycosis).
The dashed line marks 120 h: where the plane lies above the dashed white line, zebraﬁsh are deemed
to survive for the corresponding parameter values.
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rN), the inhibitory function of phagocytes (M and N), the carrying capacities of the
phagocytes (KM and KN), and the rate of fungal germination (rH). Assuming there would
be a limitation on how much these rates could be altered in reality, relatively small
changes to parameters were used, doubling or halving as appropriate, with the
exception of KM and KN, which were allowed to vary up to a total number of 50 (as
observed in experiments). We also mimicked a proinﬂammatory response, whereby in
silico phagocytes could directly clear spores and hyphae (see Fig. 5 for details of the
model alteration). The above responses were applied to the parameter sets for “sus-
ceptible” (KM  KN  12) and “immunocompromised” (KM  KN  5) zebraﬁsh, with an
aim to facilitate survival (deﬁned to occur if H  H* for all times t  120 h). Two
different proﬁles were required to protect either the “immunocompromised” or the
“susceptible” zebraﬁsh. First, the “susceptible” zebraﬁsh was receptive to a variety of
perturbations (Fig. 5A). The most efﬁcacious strategies to protect from onset of active
mucormycosis were by directly inhibiting the rate of hyphae formation (rH), doubling
the ability of immune cells to inhibit hyphae formation (N, M), or increasing the
numbers of macrophages (KM) and neutrophils (KN). The last of these, which provides
the zebraﬁsh with more phagocytes or neutrophils at the infection site than the
previously deﬁned baseline “healthy” zebraﬁsh, achieved the lowest hyphae number
over the 120-h time course, in line with the importance of phagocyte carrying capacity
in protecting from disease. An increase to only KM, KN  14 (i.e., fewer than the
“healthy” zebraﬁsh) also predicted survival until 120 h, but with formation of more
hyphae (results not shown), indicating a threshold number for partial control. In
addition, direct killing of spores and hyphae by phagocytes was predicted as a
successful strategy to support survival, with 1, 2  0.03 (where 1 and 2 are the
maximum rates of spore and hyphae killing, respectively). In contrast, the three most
effective strategies for the “susceptible” zebraﬁsh were the only three modiﬁcations
that conferred protection on the “immunocompromised” zebraﬁsh: an increase in
maximum phagocyte number at the infection site (equivalent simulation to the “sus-
ceptible” zebraﬁsh); direct killing of spores and hyphae by phagocytes, although this
needed to be at a 2-fold higher rate than for the “susceptible” zebraﬁsh (1, 2  0.06);
or a 3-fold decrease in the germination rate (rH) (as opposed to a 2-fold decrease for the
“susceptible” zebraﬁsh) (Fig. 5B).
Given the fast progression of mucormycosis and rapid hyphal growth under immu-
nosuppressed conditions, we tested the relative contributions of phagocyte carrying
capacity and inhibition of spore germination to disease establishment. Two scenarios
were used: ﬁrst, macrophage carrying capacities were increased by a relatively small
amount to KM, KN  8 (Fig. 5C); second, in addition to this increase in carrying capacity,
macrophage function (germination inhibition coefﬁcients M and N) was doubled
(Fig. 5D). Neither of these approaches in isolation was capable of ensuring the zebraﬁsh
survive the infection under this parameter set. We then combined both scenarios with
alterations to the following responses postinfection: (i) halving the hyphae formation
rate, rH; (ii) phagocyte-induced killing of hyphae and spores introduced (1, 2  0.03);
or (iii) both of the preceding. Inhibition of hyphae formation in combination with the
increased macrophage carrying capacity was protective against mucormycosis (Fig. 5C,
combination 1a), while phagocytic killing at the simulated rate did not sufﬁciently
inhibit hyphal growth, even at these enhanced macrophage levels (Fig. 5C, combina-
tion 2a). Under our parameter set, an increase in phagocytic killing is only protective
under increased germination-inhibiting potential (Fig. 5C, combination 3a). Increasing
both phagocyte numbers and function (i.e., germination inhibition coefﬁcients) proved
to be the most effective at restricting hyphal number (compare Fig. 5C and D).
Together, these in silico data suggest that a single proinﬂammatory response alone
(i.e., phagocytic recruitment or killing) may be insufﬁcient to prevent hyphal growth
and protect against fulminant mucormycosis in immunocompromised hosts.
Phagocytes control Mucor circinelloides spores in innate granulomas in vivo.
Our model indicates several protective mechanisms that would support mucormycosis
management. We therefore tested a range of these predictions.
Phagocyte Recruitment during Mucor Infection ®
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FIG 5 Simulation of protective mechanisms from onset of mucormycosis. Simulations of zebraﬁsh with (A) KM 
KN  12 and (B) KM  KN  5 were run with a proinﬂammatory response induced as indicated above the individual
plots. The responses mimicked were inducing phagocyte recruitment (rM and rN), or function (M and N), inhibiting
hyphae formation (rH), increasing maximum phagocyte number (KM, KN), and phagocyte-induced spore/hyphae
death (1, 2). For the last of these, equations 3 and 4, respectively, from Fig. 3B are altered to become
dS
dt

rHS 1S(M	 N)
KH	 S	 MM
2	 NN
2
and
dH
dt

rHS 2H(M	 N)
KH	 S	 MM
2	 NN
2
For a proinﬂammatory response to facilitate survival, the purple line must not cross the dashed line during the time
course. (C and D) Simulation of combinations of improved phagocyte carrying capacity and functionality for
“immunocompromised” zebraﬁsh. Simulations mimic an increase in phagocyte carrying capacity to KM, KN  8 in
(Continued on next page)
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First, our model indicates that proinﬂammatory signals are essential for the recruit-
ment of phagocytes. Thus, we here assessed the early (1 hpi) transcriptional response
of the proinﬂammatory cytokine gene tnf- and the chemotactic cytokine gene il-8 in
control- and dexamethasone-treated ﬁsh. We observed a signiﬁcant transcriptional
upregulation for both cytokines (tnf-, 4.1-fold; il-8, 1.9-fold) in spore-injected larvae
compared to mock-injected (PVP) larvae (P  0.05 [n  6], Mann-Whitney U test)
(Fig. 6A and B). After dexamethasone treatment, the transcriptional response for both
FIG 5 Legend (Continued)
panel C and with an additional increase in phagocyte function in panel D (M, N doubled). In combination 1, the
hyphal formation rate, rH, is halved. In combination 2, a low level of phagocyte-induced killing of hyphae and
spores is simulated (1, 2  0.03). In combination 3, both of these additional responses are induced. Each
population is illustrated: hyphae in purple, spores in yellow, macrophages in blue, and neutrophils in red. The
dashed line marks H* (the threshold number of hyphae above which zebraﬁsh are assumed to die). Survival is
predicted if the number of hyphae remains below H* during the time course simulated.
FIG 6 Phagocytes control Mucor circinelloides spores in innate granulomas in vivo. (A and B) We tested the mathematical prediction that
proinﬂammatory cytokine expression supports phagocyte recruitment by evaluating the early transcription response (1 hpi) of two
proinﬂammatory cytokine genes (tnf- and il-8, coding for tumor necrosis factor alpha and interleukin-8, respectively) after spore exposure
in control- and dexamethasone-treated ﬁsh. Dexamethasone-treated ﬁsh showed signiﬁcantly lower levels of transcript for both cytokines
(P  0.01 [n  6 with 15 ﬁsh each], Mann-Whitney U test). (C) While phagocyte-induced spore death was identiﬁed by our in silico
modeling as an efﬁcient mechanism to protect from onset of mucormycosis, and we showed rapid and robust recruitment of phagocytes
to the site of infection in vivo, spores are not cleared from zebraﬁsh larvae over a time course of 96 h after infection, as demonstrated
by CFU countings indicating live spores (P  0.229 [n  5], Kruskal-Wallis test). (D) We were able to show a lack of induction of reactive
oxygen species (ROS) in response to fungal spores compared to the ROS-inducing stimulus PMA (P  0.0001 [n  9], Mann-Whitney
U test), indicating a lack of antimicrobial activity. (E) Representative image of an innate granuloma formed of fungal spores and
macrophages (maximum-intensity projection of ﬂuorescent z-stack with 43 sections every 4 m; scale bar, 100 m). (F) Dexamethasone
treatment decreases the formation of innate granulomas (P  0.0001 [n  61], Fisher’s exact test) while increasing hyphal formation (P 
0.0001 [n  61], Fisher’s exact test) and the occurrence of spore dissemination.
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proinﬂammatory cytokines after spore injection was reduced compared to mock-
injected ﬁsh (tnf-, 0.6-fold; il-8, 0.3-fold) and signiﬁcantly lower than in untreated ﬁsh
(Fig. 6A and B) (P  0.01 [n  6], Mann-Whitney U test). These data are in agreement
with our mathematical modeling results.
Second, our model indicates spore killing by phagocytes would be an effective
protective response to infection. However, we had previously shown that spores remain
viable inside the zebraﬁsh for 48 hpi, despite rapid and robust recruitment of phago-
cytes to the site of infection (17). We now extended our assessment of spore viability
to 96 hpi, demonstrating that there is no reduction in spore viability upon infection,
even after contact with phagocytes for 96 h (Fig. 6C) (P  0.229 [n  5], Kruskal-Wallis
test). This indicates a lack of antimicrobial activity by these recruited phagocytes. The
induction of reactive oxygen species (ROS) is a well-known phagocytic mechanism to
achieve microbial killing (15, 22–25). Thus, we measured the ROS production in
response to fungal spores in the whole zebraﬁsh embryo. In comparison to an ROS-
inducing stimulus that generates ROS levels similar to those enabling Candida albicans
killing by neutrophils (26), infection with spores stimulated signiﬁcantly lower ROS
levels (P  0.0001 [n  9], Mann-Whitney U test) (Fig. 6D).
Together, these data raise the question as to how M. circinelloides is controlled in
zebraﬁsh larvae. We have previously demonstrated that, upon infection, a dense
phagocyte cluster forms around the spores (17) (Fig. 6E). We have termed this cluster
an innate granuloma. Similar innate granulomas have been described in the zebraﬁsh
larval model for Mycobacterium tuberculosis, a bacterium that is contained in granulo-
mas (27). Our in silico data predict that innate granuloma formation, which localizes
phagocytic cells to the site of infection, is important for disease control. Therefore, to
test in vivo if the formation of innate granulomas in response to infection with
M. circinelloides spores is required to control the fungal infection, we immunosup-
pressed larvae with dexamethasone and monitored innate granuloma formation, hy-
phal formation, and spore dissemination. The formation of innate granulomas was
signiﬁcantly reduced in immunosuppressed zebraﬁsh (P  0.0001 [n  61], Fisher’s
exact test) (Fig. 6F), while at the same time hyphal formation was signiﬁcantly increased
(P  0.0001 [n  61], Fisher’s exact test) (Fig. 6F), and there was an overall trend of
increasing spore dissemination (Fig. 6F).
In summary, our data demonstrate the importance of phagocyte carrying capacity
at the site of infection (Fig. 3 and 4), a lack of spore killing (Fig. 6C), and an increase of
larval mortality with lack of phagocyte recruitment to the site of infection (Fig. 2).
Together with our previously reported data demonstrating the lack of phagocyte
cluster formation after injection with dead spores (17), we propose a model in which
M. circinelloides spores establish latent infections in the host. The host in turn contains
the spores in innate granulomas, a mechanism to achieve full carrying capacity at the
site of infection, to control the fungal infection.
Latent infection with Mucor circinelloides can be activated out of innate gran-
ulomas by immunosuppression in vivo. Our in vivo spore killing and ROS data
suggest that innate granulomas control, but do not clear, fungal spores. To test our
hypothesis that latent fungal infections are controlled, but not cleared, by innate
granulomas in vivo, we reactivated fungal disease by immunosuppression with dexa-
methasone after formation of innate granulomas. Zebraﬁsh larvae were injected with
spores and screened for innate granuloma formation 24 hpi. Innate granuloma-positive
larvae were then submerged in dexamethasone-containing growth medium and mon-
itored for survival and by microscopy. Immunosuppression led to rapid mortality that
was signiﬁcantly higher (92.5%) than that in untreated, infected larvae (15.4%) (Fig. 7A)
(P  0.0001, Mantel-Cox log-rank test). It is noteworthy that control larvae exhibiting
innate granuloma formation also showed a reduced mortality compared to nonse-
lected untreated larvae (which included larvae with and without granulomas), which
had an overall mortality of 36.1% (Fig. 2A) (P  0.01, Mantel-Cox log-rank test). This
suggests some variability within the larval population that might lead to increased
susceptibility in some individuals. Microscopic examination revealed that within as little
Inglesﬁeld et al. ®
March/April 2018 Volume 9 Issue 2 e02010-17 mbio.asm.org 12
 
m
bio.asm
.org
 o
n
 April 11, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
as 3 h of treatment, innate granulomas failed to suppress spore germination and
ﬁlamentous growth (Fig. 7B), leading to complete fungal invasion and consumption of
the larvae after 48 h (Fig. 7C).
Together, these data support a model in which initial recruitment of phagocytic cells
to the site of infection supports granuloma formation, thereby ensuring high local
phagocyte number (KM, KN). Innate granulomas are sufﬁcient to control, but not clear,
the infection, and loss in maximum phagocyte number either prior to infection or after
granuloma formation leads to fulminant mucormycosis and mortality.
DISCUSSION
We here present a study investigating the temporal-spatial pattern of innate im-
munity during mucormycosis. We model the early events of innate immune recruit-
ment in response to M. circinelloides spores by a combined real-time in vivo microscopy
and in silico modeling approach. In view of our data, we propose that infection with
mucormycetes is controlled by innate granulomas, while at the same time inducing a
latent stage of infection during mucormycosis that can be reactivated by immunosup-
pression. This is an expansion of our initial observation that phagocytes accumulate at
the site of infection and that failure to do so correlates with spores being disseminated
from the site of infection. Speciﬁcally, we provide a detailed timeline for innate
FIG 7 Mucor circinelloides can be activated out of innate granulomas by immunosuppression in vivo. (A) To
investigate the potential of disease activation out of innate granulomas, we selected innate granuloma-positive
larvae and immersed them in dexamethasone-containing culture medium to induce immune suppression. While
control larvae showed 15.4% mortality, 92.5% of larvae transferred into dexamethasone-containing medium died
over the time course of this experiment. (B) Representative image showing that larvae that had succumbed to
infection presented with extensive hyphal growth (scale bar, 100 m). (C) Further microscopic examination
revealed that dexamethasone resulted in reduction in innate granuloma size and onset of hyphal growth. The top
panels show a representative innate granuloma in the hindbrain ventricle at 24 hpi (before onset of dexametha-
sone treatment) (maximum-intensity projection of ﬂuorescence z-stack with 19 sections every 4 m together with
bright-ﬁeld image and overlay, with spores [S] in cyan and macrophages [M] in red; scale bar, 100 m). The bottom
panels show the same innate granuloma at 48 hpi (24 h post-onset of dexamethasone treatment) showing hyphal
formation (arrow), reduction in innate granuloma size, and dissemination of spores (asterisks) (maximum-intensity
projection of ﬂuorescence z-stack with 36 sections every 4 m together with bright-ﬁeld image and overlay, with
spores in cyan and macrophages in red; scale bar, 100 m).
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granuloma formation and show that immunosuppression with dexamethasone reduces
innate granuloma formation. We also give insights into how spores maintain latency
within innate granulomas by reducing ROS and proinﬂammatory signals. Lastly, we
demonstrate that infection can be activated from a latent stage.
Granulomatous structures have been described in histopathological examinations
for a large spectrum of opportunistic fungal infections (e.g., cryptococcosis, mucormy-
cosis, candidiasis, and chromoblastomycosis) (28–30). However, granulomas are best
studied in the context of infections with Mycobacterium tuberculosis, the causative
agent of tuberculosis (TB). Macrophages and neutrophils can control TB by slowing
down bacterial growth during early infection, yet also function as vehicles for later
tissue dissemination (31, 32). Granuloma formation during TB may provide both a
means to control infection and also a niche for bacteria to survive, waiting for an
opportunity to break out and cause disease. It is well documented that several fungal
pathogens can survive within individual macrophages or neutrophils (e.g., Cryptococcus
neoformans [33], Candida albicans [34], and mucormycetes [35]) (Fig. 6C), dissemination
in phagocytes as trafﬁcking vehicles has been proposed for Cryptococcus neoformans
(36), and immune-inhibitory effects of infectious mucormycete spores on the innate
immune system have been reported (11, 12). To survive within a healthy host, patho-
gens need to overcome the phagocytic antimicrobial machinery. It is currently not clear
whether granuloma forms due to failure to kill a pathogen (host induced) or whether
failure to kill the bacteria is a result of granuloma formation and thus might be
pathogen induced. While innate granuloma formation during infections with opportu-
nistic M. circinelloides spores appears to have a protective role for the host by control-
ling infectious particles, granulomas might also offer a protective niche for delayed
disease activation (Fig. 7). Our zebraﬁsh infection model offers an ideal system to fully
investigate this.
Mucormycetes are emerging pathogens, with extremely high mortality rates of over
95% in those with disseminated disease (37, 38). This is due to an increase in suscep-
tible individuals, a current lack of therapeutic antifungal interventions, and a current
lack of understanding of mucormycosis pathogenesis. Mucormycosis is a suite of
diseases caused by a range of opportunistic pathogens, which indicates that healthy
individuals can effectively control the infection. Patients that present with mucormy-
cosis commonly show impaired function of effector cells of the innate immune system:
i.e., macrophages and neutrophils (1, 5, 9, 10). Thus, an improved understanding of the
mechanisms that enable fungal control in healthy individuals will expand our under-
standing of mucormycosis in susceptible patients and may inform treatment strategies.
In this study, we dissected the in vivo real-time dynamics of the innate immune
response (Fig. 1) in a zebraﬁsh larval model of mucormycosis (17). We demonstrate that
zebraﬁsh larvae initiate a global innate response to fungal spores by increasing their
phagocyte population (Fig. 1B and C) and rapidly recruit phagocytes to the site of
infection (Fig. 1D and E). This robust early phagocyte recruitment to the site of infection
provides protection from disease onset (Fig. 2). In silico mathematical modeling en-
abled us to dissect the parameters of the recruitment response conferring protection.
Interestingly, protection appears to be dependent on the number of phagocytes
(carrying capacity) at the infection site and less so on the speed of recruitment (Fig. 3).
These data expand on previous reports showing that in healthy hosts, phagocytes are
recruited to the site of infection and internalize spores in vertebrate models (4, 17,
39–42), thus offering a mechanistic explanation of how this response is disrupted in
susceptible hosts (15, 17, 40) (Fig. 2).
Our computational modeling emphasized the importance of macrophage number
on disease outcome and predicts which proinﬂammatory responses may be lacking in
zebraﬁsh who do not survive mucormycosis infection (Fig. 5). Ultimately, combining
such in silico modeling with experimental work should accelerate progress toward the
development of therapies to tackle mucormycosis and related infections. Importantly,
our data highlight the critical role of prophylactic or early infection control, presenting
a major challenge to controlling mucormycosis in the clinic. One therapeutic option
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would be to support the recruitment of macrophages (rM) and neutrophils (rN) during
the initial phases of infection. While infection may be difﬁcult to predict in a clinical
setting, the early administration times required in our model simulations for protection
against infection are relative to the predicted time of death in the zebraﬁsh larvae,
which when untreated, is around 40 h (Fig. 5B). In patients, mortality occurs within a
much more variable time frame ranging from days to months, providing a longer
working window for successful treatment.
In a clinical setting, a treatment that can be successfully delivered even in the late
stages of an infection is most desirable. While phagocytes fail to kill spores (Fig. 5C),
they can prevent the germination of spores in vivo (15, 18, 43). In susceptible hosts,
inhibition of spore germination fails, leading to ﬁlamentous growth (15, 18). Our
mathematical model further highlights the importance of inhibiting spore germination
for protection from active fungal disease. Inhibition of hyphal formation either directly
or via immune cell recruitment proved efﬁcacious and may be a plausible control
method within a helpful time period (Fig. 6B). Combinations of proinﬂammatory
responses may be capable of facilitating survival in even severely immunocompro-
mised individuals (Fig. 6).
We demonstrate in vivo lack of mucormycete spore killing and lack of reactive
oxygen burst, which together potentially result in latent fungal infection (Fig. 5C and
D). During this latent stage of infection, spores are controlled in innate granulomas in
vivo and disease can be reactivated by immunosuppression. Unlike TB and other
diseases classically associated with granuloma formation, mucormycosis is not associ-
ated with T-cell deﬁciencies, indicating that adaptive immunity has a secondary role in
the immune response to mucormycete infection (44). Our model host does not have a
developed adaptive immune system and thus relies on innate immune effectors to
respond to infectious stimuli, allowing speciﬁc dissection of the innate immune re-
sponse to infections. However, we note that T-cell responses are activated in the
context of human disease (45, 46) and might be involved in spore clearance.
Taken together, this is the ﬁrst real-time analysis of innate granuloma formation
during the early stages of a fungal infection. We have presented a novel interdisciplin-
ary strategy to understanding the interplay between the host immune response and
mucormycetes. Recent work has shown that spores induce proinﬂammatory responses
upon encountering macrophages (17, 47). Our data suggested that proinﬂammatory
signals are beneﬁcial in controlling mucormycosis by inducing phagocyte recruitment,
and both phagocyte number and activity were found to be required for protection from
disease onset. While direct phagocyte-mediated fungal killing would be promising as a
protective measure from mucormycosis in silico, our experimental results showed that
phagocytes fail to mount an effective antimicrobial response to spores. We observed a
lack of reactive oxygen burst and failure to kill fungal spores in vivo. Instead, protection
is mediated by robust phagocyte recruitment by innate immune effectors, which
drive the formation of early innate granulomas. While spores are successfully contained
in these early granulomas (innate granulomas), disease can be reactivated by
dexamethasone-induced immunosuppression, indicating the potential for a latent
infectious stage during mucormycosis that needs to be considered for clinical man-
agement of patients. While frequently observed during fungal infections, the role of
granulomas in fungal disease pathogenesis and latency has been overlooked to date.
A better understanding of the role of fungal granulomas in latency during fungal
infections has the potential to signiﬁcantly improve our clinical management of pa-
tients by enabling the identiﬁcation of individuals at risk of disease and thus informing
the need for prophylactic strategies either directly by targeting the fungal pathogen or
indirectly by immunomodulatory interventions.
MATERIALS AND METHODS
Mucor circinelloides strain and growth conditions. NRRL3631, a clinical isolate of Mucor circinel-
loides, was used in this study (35). The fungus was grown at a density of 1,000 spores per 10-cm agar
plate on Sabouraud dextrose (SAB) agar (pH 5.6) containing 0.5% (wt/vol) peptone from casein, 0.5%
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(wt/vol) peptone from meat, 4% (wt/vol) D()-glucose and 1.5% (wt/vol) agar (Merck Millipore, Watford,
United Kingdom) in the dark at room temperature (17).
Zebraﬁsh care and maintenance. Adult zebraﬁsh were kept in recirculating systems (ZebTec Active
Blue zebraﬁsh housing system; Tecniplast, London, United Kingdom) at the University of Birmingham’s
zebraﬁsh facility under a 14- to 10-h light-dark cycle and water temperature maintained at 28°C. All
zebraﬁsh care and experiments were conducted according to Home Ofﬁce legislation and the Animals
(Scientiﬁc Procedures) Act 1986 (ASPA) under Home Ofﬁce project license 40/3681 and personal licenses
l13220C2C to Kerstin Voelz and l9EE992EF to Aleksandra Jasiulewicz. Zebraﬁsh eggs were obtained by
natural mating. Eggs were collected, and 25 eggs were kept in 25 ml of E3 medium plus 0.00003%
methylene blue (Sigma-Aldrich, Irvine, United Kingdom) and 26.6 g/ml phenylthiourea (PTU; Sigma-
Aldrich, Irvine, United Kingdom) at 32°C and under a 14- to 10-h light-dark cycle thereafter. Medium was
changed every 2 days up to 5 days postfertilization (dpf). This study utilized wild-type AB zebraﬁsh as well
as transgenic zebraﬁsh Tg(mpx:GFP)i114 expressing green ﬂuorescent protein in neutrophils (48),
Tg(mpeg1:Gal4-FF)gl25 (49) crossed with Tg(UAS-E1b:NfsB.mCherry)c264 [herein referred to as Tg(mpeg1:
G/U:NfsB-mCherry)] with macrophage-speciﬁc expression of red ﬂuorescent protein mCherry and ni-
troreductase, and Tg(mpeg1:G/U:NfsB-mCherry) crossed with Tg(mpx:GFP) [herein referred to as Tg(m-
peg1:G/U:NfsB-mCherry/mpx:GFP)] with neutrophil-speciﬁc expression of green ﬂuorescent protein and
macrophage-speciﬁc expression of red ﬂuorescent protein mCherry. All zebraﬁsh care and husbandry
procedures were performed as previously described, and larvae were observed throughout the experi-
mental procedures for normal anatomical development (17, 50).
Spore preparation for injection. Prior to injections, sporangiospores were collected by gentle
washing of the mycelium with 10 ml of Dulbecco’s phosphate-buffered saline (PBS) (Sigma-Aldrich,
Irvine, United Kingdom). The spore suspension was washed with PBS, and spore numbers were enu-
merated using a hemocytometer. For visualization purposes, 108 spores were stained with 100 g/ml
Fluorescent brightener 28 (Sigma-Aldrich, Irvine, United Kingdom), washed with PBS, and resuspended
in 1 ml of 10% polyvinylpyrrolidone (PVP) (40 kDa; Sigma-Aldrich, Irvine, United Kingdom) with 0.05%
phenol red as an injection marker as previously described (17).
Hindbrain ventricle injection. Hindbrain injections were conducted as previously described (17, 51).
Brieﬂy, the developmental stage of zebraﬁsh embryos was assessed according to Kimmel et al. for
injection at the prim-25 stage (52). Embryos were manually dechorionated and anesthetized with
160 g/ml ethyl 3-aminobenzoate methanesulfonate salt (tricaine; Sigma-Aldrich, Irvine, United King-
dom). Transgenic embryos were screened and selected for expression of the cell-speciﬁc ﬂuorescent label
prior to injection. Infection doses of 100 sporangiospores per ﬁsh were achieved by microinjecting 2 nl
of a 108-spore/ml suspension in 10% PVP through the otic vesicle into the hindbrain ventricle of the
zebraﬁsh embryo; 2 nl of PVP was injected as a control. The carrier medium PVP was chosen due to its
increased density, enabling increased injection consistency and reduced clogging of microinjection
needles. Infection dose and location were conﬁrmed microscopically immediately after microinjection.
Larvae were kept in 200 l of E3 in individual wells of 96-well plates with or without chemical
manipulation. Larvae were monitored every 24 h for phagocyte numbers/recruitment, granuloma
formation, hyphal growth, dissemination, and spore and larval survival up to 5 dpf. At 5 dpf, larvae were
sacriﬁced with a tricaine overdose (10).
Chemical treatments. Immune suppression was mimicked by treatment with the steroid drug
dexamethasone (Dex) (14, 17). Larvae were immersed in E3 with 40 g/ml water-soluble dexamethasone
(Sigma-Aldrich, Irvine, United Kingdom) 4 h prior to microinjection of spores and maintained in
dexamethasone-containing E3 for survival and phagocyte recruitment studies. For reactivation studies,
larvae were transferred from E3 to E3 containing dexamethasone after formation of innate granulomas.
Spore viability assessment. Spore viability was assessed as previously described (17). Brieﬂy, after
microinjection of fungal spores, larvae were individually euthanized with a 10 overdose of tricaine and
homogenized in 100 l penicillin-streptomycin (10,000 U/ml penicillin and 10 mg/ml streptomycin;
Sigma-Aldrich, Irvine, United Kingdom) and plated onto SAB agar plates with 100 U/ml penicillin,
100 g/ml streptomycin, and 30 g/ml gentamicin (Sigma-Aldrich, Irvine, United Kingdom). Plates were
incubated at room temperature for 24 to 48 h before CFU were counted.
Fluorescence microscopy. For microscopic analysis, individually kept zebraﬁsh embryos were
anesthetized with 200 g/ml tricaine in E3 in 96-well plates. Phagocyte numbers at the site of infection
and in the whole embryos, innate granuloma formation, spore dissemination, and fungal ﬁlamentous
growth within infected embryos was assessed through a Zeiss Axio observer Z1 microscope with an
ApoTome system (Zeiss, Cambridge, United Kingdom) using objective lenses with powers of 10/0.25
numerical aperture (NA), 20/0.4 NA, and 40/0.6 NA (Zeiss, Cambridge, United Kingdom). Green
ﬂuorescent protein, mCherry, and ﬂuorescent brightener ﬂuorescent signals were detected by their
emission signals at 509 nm (excitation, 488 nm), 610 nm (excitation, 587 nm), and 465 nm (excitation,
353 nm), respectively. Images were taken and processed with the open community platform for
BioImage informatics Icy (53), and ﬁgures were compiled in Illustrator C3 (Adobe Systems, San Jose, CA,
United States). For cell tracking analysis, movies were analyzed using Volocity software (Improvision,
Coventry, United Kingdom) to determine the mean ﬂuorescence intensity of mCherry (macrophages) or
GFP (neutrophils) across the ﬁeld of view at each time point over the 12-h imaging period, and data were
normalized to the ﬁrst frame. Innate granuloma formation was deﬁned as accumulation of 10
phagocytes in a 40- by 40-m area. A spore dissemination event was recorded if there was at least one
spore that was observed outside the hindbrain ventricle compartment (17).
Measurement of reactive oxygen species production. In order to evaluate the reactive oxygen
burst induced in response to infection with fungal spores, the oxidative stress indicator chloromethyl
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derivative 5-(and-6)-chloromethyl-2=,7=-dichlorohydroﬂuorescein diacetate (CM-H2DCFDA; Invitrogen,
Fisher Scientiﬁc, Loughborough, United Kingdom) was used to measure reactive oxygen species (ROS).
Infected larvae were incubated in pairs in E3 containing 5 mM of CM-H2DCFDA in 96-well plates, and ROS
production was measured as ﬂuorescence from CM-H2DCFDA upon oxidation by ROS. Fluorescence was
measured at 520 nm (excitation, 485 to 12 nm) with the FLUOstar Omega microplate reader (BMG
Labtech, Aylesbury, United Kingdom). One hundred nanograms per milliliter phorbol 12-myristate
13-acetate (PMA; Sigma-Aldrich, Irvine, United Kingdom) was used as a positive control. Wells with dead
ﬁsh were excluded from the analysis.
qRT-PCR. One hour after injections of PVP or fungal spores into control or dexamethasone-treated
larvae, 15 ﬁsh were placed in Eppendorf tubes, euthanized with an overdose of tricaine, and homoge-
nized. Total RNA was isolated from homogenates using the PureLink RNA minikit (Thermo, Fisher
Scientiﬁc) according to the manufacturer’s instructions and reverse transcribed into cDNA using the
using iScript cDNA synthesis kit (Bio-Rad). Quantitative reverse transcription-PCR (qRT-PCR) was per-
formed using the Brilliant III Ultra-Fast SYBR green (Agilent) for arp (housekeeping gene) with forward
primer 5= CTGCAAAGATGCCCAGGGA 3= and reverse primer 5= TTGGAGCCGACATTGTCTGC 3=, tnf- with
forward primer 5= TCGCATTTCACAAGGCAATTT 3= and reverse primer 5= GGCCTGGTCCTGGTCATCTC 3=,
and il-8 with forward primer 5= GTCGCTGCATTGAAACAGAA 3= and reverse primer 5= CTTAACCCATGGA
GCAGAGG 3= (Euroﬁns Scientiﬁc). Ampliﬁcation was performed with the Aria Mx (Agilent) thermocycler
and the following conditions: 10 min of denaturation at 95°C, followed by 40 cycles of 15 s at 95°C and
1 min at 60°C. A ﬁnal dissociation curve was performed for each group. Threshold cycles (CT) and
dissociation curves were analyzed with the Aria MX software package. Gene expression levels were
normalized to zebraﬁsh arp (ΔCT) and compared with PVP-injected controls (ΔΔCT). Results are presented
as fold change (2ΔΔCT) (17, 54).
Data analysis and statistics. Data were collected from at least three independent experimental
repeats. Exact numbers of experimental repeats and embryos investigated are given where indicated in
the Results section. Data were analyzed with GraphPad Prism version 7.0a software (GraphPad, La Jolla,
CA). The statistical analysis methods for the different data sets are speciﬁed in the Results section and
ﬁgure legends. P values of 0.05 were considered statistically signiﬁcant and are indicated in the ﬁgures
as follows: *, P  0.05; **, P  0.01; and ***, P  0.001.
Mathematical model formulation. We developed an ordinary differential equation (ODE) model of
the early stages of a mucormycosis infection to explore immunomodulation effects. Related ODE models
of immunomodulation include applications to bacterial infections (55), HIV (56), and oncolysis (57), while
an agent-based model is used to explore diverse movement strategies of neutrophils toward fungal
spores in the study by Tokarski et al. (58).
Our mucormycosis infection model consists of four interacting components (Fig. 3A and B): the
population (at the site of infection) of infectious fungal spores (S), the hyphae produced by spore
germination (H), and the available pools of macrophages (M) and neutrophils (N). (Both are recruited to
the infection via the presence of spores and inhibit formation of hyphae.) In brief, we use mass action
kinetics, including saturation terms where necessary (in particular we square the numbers of macro-
phages and neutrophils on the denominator of equations 3 and 4 from panel B following a model
selection process in which this was found to improve the model ﬁt to the data), making the assumption
that the system is well mixed and spatial dependencies can be ignored. To generate the model, events
were assumed to occur as described below. Infectious spores initiate events and form hyphae at rate rH.
Macrophages are recruited to the infection site through the presence of spores at rate rM. Based on
results that neutrophils are delayed from arriving at the site of infection relative to macrophages (see
Results and Fig. 1D and E), neutrophils are assumed to be recruited in response to the presence of
macrophages at rate rN. At the site of infection, we assume that there are maximum numbers of
macrophages and neutrophils (KM and KN, respectively) that are recruited (akin to the carrying capacity
widely used in modeling in microbiology). KM and KN are ﬁxed parameters that we vary between
simulations to mimic zebraﬁsh with different immune response strengths. Macrophages and neutrophils
act independently to inhibit hyphae formation described by the rates M and N, respectively, but they
do not kill Mucorales (see Results and Fig. 5A). Death of immune cells is negligible over the time course
of interest. We note that we have investigated the possibility that hyphae also attract macrophages to
the infection site, but as hyphae formation is generally established as the phagocytes are approaching
carrying capacity, this had no qualitative effect on our results; we therefore omit this possibility for
simplicity.
Mathematical model parameterization. Initial numbers of macrophages, neutrophils, and hyphae
at the site of the infection were set to 0 based on in vivo observations, while the initial number of spores
was 100 (as per the experimental protocol). Parameterization was performed by minimizing an appro-
priate objective function using fminsearch in MATLAB. Estimates of the recruitment rates rM and rN were
based on the time series raw data of the recruitment in vivo assays (see Results and Fig. 1D and E; with
objective function the sum of the l2-norm of the model errors for macrophage and neutrophil count
using a reduced model for phagocyte recruitment only). Note that though the units are different
between these data and the variables in the model (and there is currently no obvious means to convert
between the two), we have used the data to obtain information about the relative sizes of these two
parameters. To address this uncertainty, these (and indeed all) parameters are subject to sensitivity
analyses performed later in the study.
KM and KN are assumed to vary between zebraﬁsh and were taken as the number of macrophages
and neutrophils, respectively, at the infection site after 24 h (see Table S1 in the supplemental material)
as experimental observations indicate phagocyte numbers have saturated by this time point. The full
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model was simulated against these data, and the objective function was used to estimate the remaining
parameters. The objective function is given by the l2-norm of the vector, vi, where for i  1 . . . 16
(deceased ﬁsh [Table S1A])
vi 
0 if ti
s (t
i
* 24, t
i
*],
(t
i
* 24) ti
s if ti
s
 t
i
* 24,
ti
s t
i
* if ti
s t
i
*
with ti
s and ti
*, the simulated and recorded death times, respectively. (Note that a ﬁsh may have died at
any point in the 24 h preceding the recorded death time.) For i  17 . . . 36 (ﬁsh surviving to 120 h
[Table S1B]), vi  max120  ti
s, 0.
To calculate a simulated time of death, it is assumed that hyphae amass until they reach a critical
value, termed H*, at which point host damage is correspondent with death. (H* must also be estimated
as part of the parameterization process.) Latin hypercube sampling was used to generate a range of
starting guesses (fminsearch is a local optimizer). We subsequently explored a range of promising
parameter sets that gave equivalent qualitative results throughout. We present only one of these here
(that which gave the lowest obtained objective function value): rM  0.013 (h1), rN  0.033 (h1), rH 
2.32 (h1), M 1.30 (fungal cells)(immune cells)1, N 1.02 (fungal cells)(immune cells)1, H* 58.85
(fungal cells), and KH  1.12 (fungal cells), with KN and KM taken for each zebraﬁsh from Table S1A and
B. Results of this parameterization are given in Fig. S3A and B in the supplemental material. We note that
where required fold changes in parameters for speciﬁc outputs are stated in Results, these are given for
comparison purposes between cases investigated within one parameter set and may differ for alternative
parameter sets (while remaining qualitatively equivalent).
Ethics statement. All zebraﬁsh care and experiments were conducted according to Home Ofﬁce
legislation and the Animals (Scientiﬁc Procedures) Act 1986 (ASPA) under Home Ofﬁce project license
40/3681 and personal licenses l13220C2C to Kerstin Voelz and l9EE992EF to Aleksandra Jasiulewicz.
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